Loading
Inhibitor Therapeutics, Inc. Stock: price and insider trades · United States
US·Mcap US$13.8M
Inhibitor Therapeutics, Inc.: what insiders have been doing
Inhibitor Therapeutics, Inc. is a listed company. Its insiders report their share dealings to SEC (Form 4). The last twelve months, up to 18 October 2026, brought 6 filings signed by 6 insiders.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Compared with its exchange (5,808 companies, median 19 filings), a count of 6 filings is below the norm.
Insider buying of Inhibitor Therapeutics, Inc. has been absent for the past year.
For comparison within the same market, see the insider buying recorded at GameStop Corp. and Heico Corp. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Insider Decl.
18
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Financial data
as of FY 2025FY ended December 2025 · cache
US$0.08
Analyst consensus
Income statement
EBITDA-US$3.4M
Net income-US$3.3M0.0% margin
Valuation
Beta-0.68
Balance sheet & cash
Market capUS$13.8M
Total debtUS$61.6k
Free Cash Flow-US$3.2M
Profitability & ownership
ROA-92.7%
% insiders55.1%
% institutions0.0%
Last declaration on 4 August 2026
Declarations18 total
3,200,000 shares0Common StockSEC:0001493152-26-036080:0
50,000 shares0Common StockSEC:0001493152-26-035950:0
50,000 shares0Common StockSEC:0001493152-26-035953:0
50,000 shares0Common StockSEC:0001493152-26-035955:0
50,000 shares0Common StockSEC:0001493152-26-035962:0
50,000 shares0Common StockSEC:0001493152-26-029898:0
50,000 shares0Common StockSEC:0001641172-25-003556:0
50,000 shares0Common StockSEC:0001641172-25-003025:0
50,000 shares0Common StockSEC:0001641172-25-003029:0
50,000 shares0Common StockSEC:0001641172-25-003033:0
50,000 shares0Common StockSEC:0001641172-25-003023:0
50,000 shares0Common StockSEC:0001493152-24-020172:0
50,000 shares0Common StockSEC:0001493152-24-020171:0
50,000 shares0Common StockSEC:0001493152-24-020170:0
50,000 shares0Common StockSEC:0001493152-24-020173:0
25,000 shares0Common StockSEC:0000950170-23-045043:0
79,627,069 shares0Common StockSEC:0000899243-23-013201:0
796,271 shares0Common StockSEC:0000899243-23-013195:0
18 of 18 declarations
About Inhibitor Therapeutics, Inc.
Inhibitor Therapeutics, Inc. is a company focused on developing innovative therapies for serious diseases. It is listed on the XNAS market.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations
